74 related articles for article (PubMed ID: 12944586)
1. Toxicological and structural features of organophosphorus and organosulfur cannabinoid CB1 receptor ligands.
Segall Y; Quistad GB; Sparks SE; Nomura DK; Casida JE
Toxicol Sci; 2003 Nov; 76(1):131-7. PubMed ID: 12944586
[TBL] [Abstract][Full Text] [Related]
2. Lysophospholipase inhibition by organophosphorus toxicants.
Quistad GB; Casida JE
Toxicol Appl Pharmacol; 2004 May; 196(3):319-26. PubMed ID: 15094302
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications.
Quistad GB; Sparks SE; Segall Y; Nomura DK; Casida JE
Toxicol Appl Pharmacol; 2002 Feb; 179(1):57-63. PubMed ID: 11884237
[TBL] [Abstract][Full Text] [Related]
4. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
Wu SY; Casida JE
Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903
[TBL] [Abstract][Full Text] [Related]
5. Evidence that mouse brain neuropathy target esterase is a lysophospholipase.
Quistad GB; Barlow C; Winrow CJ; Sparks SE; Casida JE
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7983-7. PubMed ID: 12805562
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid CB1 receptor as a target for chlorpyrifos oxon and other organophosphorus pesticides.
Quistad GB; Nomura DK; Sparks SE; Segall Y; Casida JE
Toxicol Lett; 2002 Sep; 135(1-2):89-93. PubMed ID: 12243867
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.
Pinto JC; Potié F; Rice KC; Boring D; Johnson MR; Evans DM; Wilken GH; Cantrell CH; Howlett AC
Mol Pharmacol; 1994 Sep; 46(3):516-22. PubMed ID: 7935333
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.
Makhaeva GF; Filonenko IV; Yankovskaya VL; Fomicheva SB; Malygin VV
Neurotoxicology; 1998; 19(4-5):623-8. PubMed ID: 9745921
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
Chen RZ; Frassetto A; Lao JZ; Huang RR; Xiao JC; Clements MJ; Walsh TF; Hale JJ; Wang J; Tong X; Fong TM
Eur J Pharmacol; 2008 Apr; 584(2-3):338-42. PubMed ID: 18336811
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Showalter VM; Compton DR; Martin BR; Abood ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
[TBL] [Abstract][Full Text] [Related]
11. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase.
Moretto A; Bertolazzi M; Lotti M
Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor acetylhydrolase: selective inhibition by potent n-alkyl methylphosphonofluoridates.
Quistad GB; Fisher KJ; Owen SC; Klintenberg R; Casida JE
Toxicol Appl Pharmacol; 2005 Jun; 205(2):149-56. PubMed ID: 15893542
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
[TBL] [Abstract][Full Text] [Related]
14. Avian embryonic brain reaggregate culture system. II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure.
Funk KA; Liu CH; Higgins RJ; Wilson BW
Toxicol Appl Pharmacol; 1994 Jan; 124(1):159-63. PubMed ID: 8291056
[TBL] [Abstract][Full Text] [Related]
15. Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor.
Deng H; Gifford AN; Zvonok AM; Cui G; Li X; Fan P; Deschamps JR; Flippen-Anderson JL; Gatley SJ; Makriyannis A
J Med Chem; 2005 Oct; 48(20):6386-92. PubMed ID: 16190764
[TBL] [Abstract][Full Text] [Related]
16. The homeostasis of phosphatidylcholine and lysophosphatidylcholine in nervous tissues of mice was not disrupted after administration of tri-o-cresyl phosphate.
Hou WY; Long DX; Wu YJ
Toxicol Sci; 2009 Jun; 109(2):276-85. PubMed ID: 19349639
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC
Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458
[TBL] [Abstract][Full Text] [Related]
18. Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors.
Segall Y; Quistad GB; Nomura DK; Casida JE
Bioorg Med Chem Lett; 2003 Oct; 13(19):3301-3. PubMed ID: 12951114
[TBL] [Abstract][Full Text] [Related]
19. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors.
Govaerts SJ; Hermans E; Lambert DM
Eur J Pharm Sci; 2004 Nov; 23(3):233-43. PubMed ID: 15489124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
